Patents by Inventor Luca Battistini

Luca Battistini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1H-[1,2,4]-triazole for the treatment of autoimmune diseases
    Publication number: 20050026980
    Abstract: The present invention discloses a method for treating a subject affected by an autoimmune disease, in particular multiple sclerosis, lupus erythematosus systemicus and rheumatoid arthritis, comprising administering to said subject an effective amount of 3-(2-ethylphenyl)-5-methoxy-1H-1,2,4-tirazole. The present invention further discloses a method for inhibiting ?? T cells in a subject in need thereof, said method comprising administering to said subject an effective amount of the same compound.
    Type: Application
    Filed: March 30, 2004
    Publication date: February 3, 2005
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Luca Battistini, Giovanna Borsellino, Rita De Santis, Paolo Carminati
  • Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases
    Patent number: 6797722
    Abstract: The present invention discloses a method for treating a subject affected by an autoimmune disease, in particular multiple sclerosis, lupus erythematosus systemicus and reumatoid arthritis, comprising administering to said subject an effective amount of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole. The present invention further discloses a method for inhibiting &ggr;&dgr; T cells in a subject in need thereof, said method comprising administering to said subject an effective amount of the same compound.
    Type: Grant
    Filed: May 3, 2002
    Date of Patent: September 28, 2004
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Luca Battistini, Giovanna Borsellino, Rita De Santis, Paolo Carminati
  • USE OF 3-(2-ETHYLPHENYL)-5-(3-METHOXYPHENYL)-1H-1,2,4-TRIAZOLE FOR THE TREATMENT OF AUTOIMMUNE DISEASES
    Publication number: 20030207931
    Abstract: The present invention discloses a method for treating a subject affected by an autoimmune disease, in particular multiple sclerosis, lupus erythematosus systemicus and reumatoid arthritis, comprising administering to said subject an effective amount of 3-(2-ethylphenyl)5-methoxy-1H-1,2,4-triazole. The present invention further discloses a method for inhibiting &ggr;&dgr; T cells in a subject in need thereof, said method comprsing administering to said subject an effective amount of the same compound.
    Type: Application
    Filed: May 3, 2002
    Publication date: November 6, 2003
    Inventors: Luca Battistini, Giovanna Borsellino, Rita De Santis, Paolo Carminati